ClearThink 1 Acquisition
CTAAR · NASDAQ
$0.1517−$0.0033 (−2.13%)TodayMarket closed ·
Prev close $0.155
CTAAR key statistics
- Market cap
- —
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 381
- Volume
- 900
- Open price
- $0.1513
- High today
- $0.1898
- Low today
- $0.1512
- 52 Week high
- $0.26
- 52 Week low
- $0.1512
ClearThink 1 Acquisition (CTAAR) at a glance
ClearThink 1 Acquisition (CTAAR) last traded at $0.1517, with a price-to-earnings ratio of 0.00.
Today the stock has traded between $0.1512 and $0.1898. The current price is 0.3% above the day's low and 20.1% below its high.
Volume so far is 900 shares, above the average of 381 shares a day.
Over the past year ClearThink 1 Acquisition has ranged from $0.1512 to $0.26, and now sits 0% of the way up that range.
CTAAR news
12 Industrials Stocks Moving In Wednesday's Intraday Session
12 Industrials Stocks Moving In Friday's Intraday Session
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.